Omzo vs Trimi: Compounded Semaglutide Pricing and Care Compared
Omzo vs Trimi compares two telehealth-first services for compounded semaglutide and tirzepatide. Early verdict: Omzo emphasizes clinician-guided, personalized plans and compounded medication options starting at $179, while Trimi highlights lower flat pricing from $99/month, free overnight shipping, and a 6-month money-back promise.
Start Omzo clinician-guided care
Top differences at a glance in Omzo vs Trimi
This comparison focuses on five distinctive differences supported by the sources: pricing and pricing model, medication type and FDA status, clinical oversight, shipping and refund policies, and membership scope. Each point contrasts Omzo and Trimi directly using only supplied facts.
Pricing and pricing model
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. Pricing is presented as personalized, clinician-guided and included in Omzo fees where medication costs are part of the fees collected. Trimi advertises compounded semaglutide from $99/month on an annual plan and tirzepatide $125/month with flat pricing that does not rise as dose increases.
Medication type and regulatory status
Both providers offer compounded semaglutide and tirzepatide prescribed by U.S.-licensed clinicians. Omzo explicitly states its primary program provides access to compounded medications that are not FDA-approved and that these compounded drugs have not been reviewed by the FDA for safety, effectiveness, or quality. Trimi also notes that compounded medications are prepared per individual prescription and are not themselves FDA-approved. Both sources preserve the regulatory qualifier that compounded medications are not FDA-approved.
Clinical oversight and provider networks
Omzo connects users with licensed medical providers who review plans and determine eligibility; clinical services are provided by third party networks of U.S.-licensed clinicians who make final prescribing decisions. Trimi states prescriptions and clinical oversight come from licensed U.S. providers through Arora Health, led by a named medical director, and claims a board-certified physician founded the clinical network. Trimi also references named compounding pharmacies and a certificate of analysis available on request.
Shipping, membership scope, and refunds
Omzo mentions fast, discreet delivery and FSA & HSA eligibility, with medication costs included in fees Omzo collects and pays to pharmacies. Omzo also warns that eligibility, pharmacy, state coverage and renewal terms may change. Trimi advertises free overnight, temperature-controlled shipping and flat pricing with the same price at every dose, plus a 6-month money-back promise if you do not lose weight subject to terms. Trimi notes an automatic refund if not approved by their medical team.
Explore Omzo medication options
| Criteria | Omzo | Trimi |
|---|---|---|
| Starting price | $179 for semaglutide; $279 for tirzepatide | Semaglutide from $99/mo on annual plan; tirzepatide $125/mo |
| Pricing model | Personalized, clinician-guided; medication costs included in fees | Flat pricing that never rises as dose increases; same price at every dose |
| Medication type | Compounded semaglutide and tirzepatide; compounded meds not FDA-approved | Compounded semaglutide and tirzepatide; compounded meds not FDA-approved |
| Clinical oversight | Licensed U.S. providers in third party networks review and prescribe | Licensed U.S. providers through Arora Health; named medical director and board-certified physician leadership |
| Shipping | Fast, discreet delivery; FSA & HSA eligible | Free overnight, temperature-controlled shipping |
| Refunds/guarantees | No guarantees; results may vary and eligibility not guaranteed | 6-month money-back promise and automatic refund if not approved by medical team; terms apply |
How each handles expectations and regulatory notes
Omzo repeatedly states that compounded medications it offers are not FDA-approved and that individual results are not guaranteed. It also clarifies that Omzo is not a medical practice and that providers determine eligibility and prescribing. Trimi similarly says compounded medications are not FDA-approved, cites peer-reviewed trials for active ingredients but does not guarantee individual results, and provides named compounding pharmacies with certificates of analysis available on request.
Check Trimi clinical oversight and policies
Final comparison and recommendation
Both Omzo and Trimi offer compounded semaglutide and tirzepatide under telehealth models with licensed U.S. clinicians. If price and flat predictable billing are your priority, Trimi advertises lower monthly rates on annual plans, free overnight shipping, and a 6-month money-back promise. If you prefer clinician-guided, personalized plans where medication costs are included in service fees and an emphasis on personalized provider review, Omzo presents that model with semaglutide starting at $179.
Choose one based on these facts
- Choose Trimi if you want flat, lower advertised monthly pricing from $99/mo on an annual plan, free overnight shipping, and a stated 6-month money-back promise subject to terms.
- Choose Omzo if you want clinician-guided, personalized compounded medication plans where medication costs are included in fees and semaglutide is listed starting at $179, noting that compounded medications are not FDA-approved.